Works matching IS 10600280 AND DT 2022 AND VI 56 AND IP 9
Results: 16
A Scoping Review Evaluating the Effect of SGLT-2 Inhibitors on Insulin Dose Requirements in Insulin-Dependent Patients With Type 2 Diabetes.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1030, doi. 10.1177/10600280211071089
- By:
- Publication type:
- Article
Inclusion of Optimal Guidelines for Pharmacists in UpToDate.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Safety and Efficacy of Various Intravenous Insulin Infusion Rates in Patients With and Without Diabetes Presenting With Hypertriglyceridemia.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1016, doi. 10.1177/10600280211070102
- By:
- Publication type:
- Article
Dark Red Urine in a Patient on Cefiderocol and Ferric Gluconate.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1082, doi. 10.1177/10600280211070029
- By:
- Publication type:
- Article
Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1007, doi. 10.1177/10600280211068177
- By:
- Publication type:
- Article
Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 981, doi. 10.1177/10600280211064306
- By:
- Publication type:
- Article
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1049, doi. 10.1177/10600280211070330
- By:
- Publication type:
- Article
Cerebral Venous Sinus Thrombosis in a Young Body Builder Man With Androgen Use.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1079, doi. 10.1177/10600280211063883
- By:
- Publication type:
- Article
Balanced Crystalloid Versus Normal Saline as Resuscitative Fluid in Diabetic Ketoacidosis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 998, doi. 10.1177/10600280211063651
- By:
- Publication type:
- Article
Medication Changes and Diagnosis of New Chronic Illnesses in COVID-19 Intensive Care Unit Survivors.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 973, doi. 10.1177/10600280211063319
- By:
- Publication type:
- Article
Severe Hypocalcemia Due to Skeletal Remineralization After Venetoclax, Bortezomib, and Dexamethasone for Relapsed Multiple Myeloma.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1076, doi. 10.1177/10600280211062626
- By:
- Publication type:
- Article
Evidence Needed for Efficacy of Antidepressant Medications Among Patients With Rheumatoid Arthritis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1065, doi. 10.1177/10600280211062271
- By:
- Publication type:
- Article
A Retrospective Characterization of Dexmedetomidine-Suspected Fever and Its Consequences in Adult Critically Ill Patients.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1023, doi. 10.1177/10600280211060082
- By:
- Publication type:
- Article
Finerenone: A Novel Mineralocorticoid Receptor Antagonist for Cardiorenal Protection in CKD and T2DM.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1041, doi. 10.1177/10600280211059577
- By:
- Publication type:
- Article
Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 988, doi. 10.1177/10600280211059040
- By:
- Publication type:
- Article
Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1058, doi. 10.1177/10600280211058387
- By:
- Publication type:
- Article